Roche Diabetes Care, Inc.

Roche Diagnostics Operations, Inc.

Roche Diagnostics Gmbh

Roche Diagnostics International Ag

F. Hoffmann-la Roche Ag

Michael Schoemaker

Sebastiaan La Bastide

Matthias Essenpreis

Ulrich Haueter

Michael Marquant

Stefan Weinert

Robert E Reinke

Bernd Roesicke

Gregor Bainczyk

Stefan Lindegger

Nicole Bernini

Otto Gaa

Robin S Wagner

Gerhard Frisch

Joerg Scherer

Kelly Heaton

Wilfried Schmidt

Uwe Wittmann

Karin Schwind

Derek Brandt

Andreas Menke

Sandro Niederhäuser

Timothy Peter Engelhardt

Joel Jeckelmann

Gunnar Meyer Olden

Theodor Koschinsky

Sascha Heckermann

Karin Obermaier

Martin Mueri

Gunnar Meyer-Olden

Sebastiaan Labastide

Christian Hoerauf

Josef Roeper

Sybille Fankhauser

Sybille Kaeser

Sebastiaan LaBastide

Sybille KÄSER-Fankhauser

Sybille Frankhauser

Martin Müri

Jörg Scherer

An ambulatory medical device and a method of communication between medical devices are disclosed. In one embodiment, the medical device includes a module for communication with at least a second medical device wherein the module for communication is adapted to be activated by a value of a physiological parameter of an animal. In one embodiment, the method of the present invention involves a first medical device and at least a second medical device wherein the communication between said medical devices is activated by a value of a physiological parameter of an animal.

Ambulatory medical device and method for communication between medical devices

A handheld diabetes management device for managing blood glucose test data and continuous glucose monitoring data includes a port configured to receive a test strip, a wireless transceiver, a communications processor, and a user interface processor. The communications processor communicates with the wireless transceiver to periodically collect glucose measurement data from a continuous glucose monitoring device and to store the glucose measurement data in a first data storage module. The communications processor is operable to consume electrical power at a first rate. The user interface processor communicates with the communication processor to receive the glucose measurement data and operable to display the glucose measurement data on the device. The communications processor operates asynchronously from operation of the user interface processor to collect the glucose measurement data and the user interface processor operates to consume electrical power at a second rate that is higher than the first rate.

Diabetes manager for glucose testing and continuous glucose monitoring

A method for diabetes care, the method (which also may be referred to as, involve or incorporate at least one of a tool, device or program) allowing for the characterization of the relevance of errors of parameters affecting glucose concentration on a postprandial glucose concentration outcome for a person with diabetes mellitusm, wherein the method involves at least one of sensing, determining, calculating, predicting, describing and communicating the effects of potential errors of parameters affecting glucose concentration on postprandial glucose concentration values within a clinically relevant glucose range.

System, tools, devices and a program for diabetes care

The analyte concentration, such as glucose, in a human or animal body is measured with an implantable sensor that generates measurement signals. The measurement signals are compressed through statistical techniques to produced compressed measurement data that can is easier to process and communicate. A base station carries the implantable sensor along with a signal processor, memory, and a transmitter. A display device is also disclosed that can receive the compressed measurement data from the base station for further processing and display.

Method of compression data from in-vivo measurements of an analyte concentration in a human

System for in-vivo measurement of an analyte concentration

The invention concerns a microdialysis system comprising a microdialysis probe ( ) that can be inserted into organic tissue ( ) and has a dialysis membrane ( ) to separate a probe channel ( ) filled with perfusion fluid from the tissue ( ), a sensor cell ( ) to determine the concentration of components and especially glucose in the perfusion fluid that is conveyed from the microdialysis probe ( ) and a transport device ( ) to convey the perfusion fluid through the probe channel ( ) of the microdialysis probe ( ) to the sensor cell ( ). In order to enable a substantially pressureless transport of perfusion fluid through the microdialysis probe and thus to prevent undesired passage of fluid through the dialysis membrane ( ), it is proposed that the transport device ( ) has a pressure pump unit ( ) connected on the pressure side to the inlet ( ) of the probe channel ( ) and a suction pump unit ( ) connected on the suction side to the outlet ( ) of the probe channel ( ) that can be operated simultaneously with the pressure pump unit ( ).

Microdialysis system

Growing community of inventors

Mannheim, Germany

Michael Schoemaker